Core Viewpoint - WillScot Holdings Corporation has amended its asset-based lending credit facility to reduce borrowing costs and extend the maturity date to October 16, 2030, enhancing its liquidity position and growth capacity [1][2]. Summary by Sections Credit Facility Amendments - The credit facility has been right-sized to $3.0 billion, with an accordion feature expanded to $1.0 billion, allowing for significant growth capacity [2][4]. - The interest rate spreads above Term SOFR and Term CORRA have been reduced to a maximum of 137.5 basis points, down from 160 basis points, resulting in initial savings of 22.5 basis points [2][3]. Financial Impact - The company anticipates annual cash interest expense savings of approximately $5.0 million at current borrowing levels, with potential for further reductions [2]. - Additional interest rate reductions of 12.5 basis points will occur after September 30, 2026, if certain conditions regarding average availability and net leverage are met [3]. Current Financial Position - As of the transaction close, WillScot had approximately $1.4 billion in available borrowing capacity under the amended facility [4]. - The aggregate principal amount of the credit facility has been reduced from $3.7 billion to $3.0 billion, which will lower undrawn line fees [4]. Institutional Support - The amended facility is supported by a syndicate of financial institutions, with Bank of America N.A. serving as the Administrative Agent and Collateral Agent [5].

Core Viewpoint - Cannara Biotech Inc. has amended its credit facility with Bank of Montreal to include a $10 million upsize, aimed at funding the initial post-harvest expansion at its Valleyfield facility, which supports the company's long-term goal of achieving an annual production capacity of 100,000 kg [1][5]. Financial Flexibility and Growth Strategy - The amendments to the credit facility reflect confidence in Cannara's growth strategy and operational performance, as stated by the President & CEO [2]. - The company is positioned to execute the expansion of its Valleyfield facility with improved financial flexibility and reduced financing costs, while maintaining a strong balance sheet [3]. Capital Expenditures Facility - The Restated Credit Facility includes a $10 million committed delayed capital expenditures debt facility, available through multiple draws until July 2026, with a 10-year amortization schedule [4]. - This facility will fund the initial phase of Cannara's post-harvest expansion, enhancing capabilities in hang-drying, freezing, trimming, packaging, and butane extraction [5]. Interest Rate Reduction - Cannara secured a total 50-basis-point reduction in the interest rate spread under the Restated Credit Facility, decreasing the overall cost of debt from over 8% in 2024 to below 6% [8]. - The company achieved this reduction through meeting certain covenant thresholds, resulting in significant savings in interest expenses [8]. Removal of Limited Recourse Guarantee - The company successfully eliminated a limited recourse guarantee provided by a related party, which reduced annual interest expense by approximately $375,000, thereby strengthening its capital structure [8].

Core Viewpoint - Auxly Cannabis Group Inc. has entered into two significant agreements aimed at strengthening its balance sheet, reducing debt, and supporting long-term growth [1][2] Group 1: Financial Transactions - The company has amended its credit facility, which will enhance liquidity and provide flexibility for capital allocation towards strategic growth initiatives [1][3] - The settlement of the Imperial Brands convertible debenture through equity issuance will eliminate over $21 million of debt from the balance sheet, improving capital structure and reducing interest obligations [1][2][5] Group 2: Credit Facility Details - The amended credit facility will consist of a total of $50.7 million, including a term loan of $36.2 million and a revolving facility of $10 million for working capital [6] - The term of the facility is two years with an option to extend for an additional year, and it will be secured by substantially all assets of the company and its subsidiaries [6] Group 3: Imperial Brands Settlement - The exchange agreement with Imperial Brands will convert approximately $1 million principal and $1.39 million of accrued interest into shares, resulting in Imperial owning approximately 19.9% of the company post-settlement [8][15] - The total consideration for the shares and warrants issued to Imperial Brands is approximately $9.8 million, reflecting the settlement of the indebtedness owed under the debenture [15]